Obesity-inducing diet promotes acylation stimulating protein resistance

Biochemical and Biophysical Research Communications

Volumn 437, Issue 3, 2013, Pages 403-407

  Fisette, Alexandre ^a   Lapointe, Marc ^a   Cianflone, Katherine ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Acylation stimulating protein; Adipokine; Lipid metabolism; Obesity; Resistance

Indexed keywords

ACYLATION STIMULATING PROTEIN; FAT; LIPOPROTEIN RECEPTOR; PROTEIN KINASE B; RECOMBINANT PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CLEARANCE; COMORBIDITY; CONTROLLED STUDY; EX VIVO STUDY; LIPID METABOLISM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ACYLATION STIMULATING PROTEIN; ADIPOKINE; AREA UNDER THE CURVE; ASP; AUC; GAPDH; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; HF/HS; HIGH-FAT HIGH-SUCROSE; LF; LIPID METABOLISM; LOW-FAT; OBESITY; RESISTANCE; TG; TRIGLYCERIDE;

ADIPOSE TISSUE; ANIMAL FEED; ANIMALS; COMPLEMENT C3A; COMPLEMENT C5A; DIET; DIETARY FATS; HUMANS; MALE; MICE; MICE, INBRED C57BL; OBESITY; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY;

ANIMALIA; MUS;

EID: 84880927222     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.090     Document Type: Article

References (28)

1. Cianflone K., Xia Z.N., Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochimica et Biophysica Acta-Biomembranes 2003, 1609:127-143.
2. Saleh J., Blevins J.E., Havel P.J., Barrett J.A., Gietzen D.W., Cianflone K. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. International Journal of Obesity 2001, 25:705-713.
3. Murray I., Sniderman A.D., Cianflone K. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. Journal of Lipid Research 1999, 40:1671-1676.
4. Van Hermelen V., Reynisdottir S., Cianflone K., Degerman E., Hoffstedt J., Nilsell K., Sniderman A., Arner P. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. Journal of Biological Chemistry 1999, 274:18243-18251.
5. Fisette A., Munkonda M.N., Oikonomopoulou K., Paglialunga S., Lambris J.D., Cianflone K. C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. Immunobiology 2013, 218:127-133.
6. Munkonda M.N., Lapointe M., Miegueu P., Roy C., Gauvreau D., Richard D., Cianflone K. Recombinant acylation stimulating protein administration to c3(-) mice increases insulin resistance via adipocyte inflammatory mechanisms. PLoS ONE 2012, 7.
7. Gao H.W., Neff T.A., Guo R.F., Speyer C.L., Sarma J.V., Tomlins S., Man Y.F., Riedemann N.C., Hoesel L.M., Younkin E., Zetoune F.S., Ward P.A. Evidence for a functional role of the second C5a receptor C5L2. Federation Of American Societies For Experimental Biology Journal 2005, 19:1003-1005.
8. Chen N.J., Mirtsos C., Suh D., Lu Y.C., Lin W.J., McKerlie C., Lee T., Baribault H., Tian H., Yeh W.C. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007, 446:203-207.
9. Kalant D., MacLaren R., Cui W., Samanta R., Monk P.N., Laporte S.A., Cianflone K. C5L2 is a functional receptor for acylation-stimulating protein. Journal of Biological Chemistry 2005, 280:23936-23944.
10. Cui W., Lapointe M., Gauvreau D., Kalant D., Cianflone K. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Molecular Immunology 2009, 46:3207-3217.
11. Johswich K., Klos A. C5L2 an anti-inflammatory molecule or a receptor for acylation stimulating protein (C3a-desArg)?. Current Topics in Innate Immunity 2007, 598:159-180.
12. Cui W., Simaan M., Laporte S., Lodge R., Cianflone K. C5a-and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Molecular Immunology 2009, 46:3086-3098.
13. Maslowska M., Legakis H., Assadi F., Cianflone K. Targeting the signaling pathway of acylation stimulating protein. Journal of Lipid Research 2006, 47:643-652.
14. Saleh J., Summers L.K.M., Cianflone K., Fielding B.A., Sniderman A.D., Frayn K.N. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. Journal of Lipid Research 1998, 39:884-891.
15. Onat A., Can G., Rezvani R., Cianflone K. Complement C3 and cleavage products in cardiometabolic risk. Clinica Chimica Acta 2011, 412:1171-1179.
16. Cianflone K., Zakarian R., Couillard C., Delplanque B., Despres J.P., Sniderman A. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. Journal of Lipid Research 2004, 45:124-131.
17. Wen Y., Wang H.W., MacLaren R., Lu H.L., Hu X.F., Cianflone K. Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 2008, 105:404-413.
18. Poursharifi P., Lapointe M., Hebert T., Cianflone K. C5L2 and C5aR interaction in adipocytes and macrophages: insight into adipoimmunology. Obesity 2011, 19:S75.
19. Tahiri Y., Karpe F., Tan G.D., Cianflone K. Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutrition and Metabolism 2007, 4.
20. Gao Y., Gauyreau D., Cianflone K. Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 2010, 109:896-905.
21. Lu H., Gauvreau D., Lapointe M., Luo X.P., Cianflone K. Inflammatory markers and adipokines alter adipocyte-derived ASP production through direct and indirect immune interaction. Experimental and Clinical Endocrinology & Diabetes 2013, 121:194-200.
22. MacLaren R., Kalant D., Cianflone K. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochemistry and Cell Biology 2007, 5:11-21.
23. Scantlebury T., Maslowska M., Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. Journal of Biological Chemistry 1998, 273:20903-20909.
24. Wen Y., Wang H., MacLaren R., Wu J., Lu H., Cianflone K. Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. Journal of Cellular Biochemistry 2008, 104:391-401.
25. Tom F.Q., Gauvreau D., Lapointe M., Lu H., Poursharifi P., Luo X.P., Cianflone K. Differential chemoattractant response in adipocytes and macrophages to the action of acylation stimulating protein. European Journal of Cell Biology 2013, 92:61-69.
26. Fisette A., Poursharifi P., Oikonomopoulou K., Munkonda M.N., Lapointe M., Cianflone K. Paradoxical glucose-sensitizing yet proinflammatory effects of acute asp administration in mice. Mediators of Inflammation 2013, Epub ahead of print.
27. Tahiri Y., Karpe F., Tan G.D., Cianflone K. Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutrition Metabolism, Lond 2007, 4:11.
28. Faraj M., Sniderman A.D., Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. Journal of Lipid Research 2004, 45:657-666.